GSK plc (GLAXF)

USD 17.26

(-0.4%)

Total Liabilities Summary of GSK plc

  • GSK plc's latest annual total liabilities in 2023 was 46.21 Billion GBP , down -7.67% from previous year.
  • GSK plc's latest quarterly total liabilities in 2024 Q1 was 45.28 Billion GBP , down -2.01% from previous quarter.
  • GSK plc reported annual total liabilities of 50.05 Billion GBP in 2022, down -13.35% from previous year.
  • GSK plc reported annual total liabilities of 57.76 Billion GBP in 2021, down -3.12% from previous year.
  • GSK plc reported quarterly total liabilities of 45.28 Billion GBP for 2024 Q1, down -2.01% from previous quarter.
  • GSK plc reported quarterly total liabilities of 47.3 Billion GBP for 2023 Q2, up 0.04% from previous quarter.

Annual Total Liabilities Chart of GSK plc (2023 - 1989)

Historical Annual Total Liabilities of GSK plc (2023 - 1989)

Year Total Liabilities Total Liabilities Growth
2023 46.21 Billion GBP -7.67%
2022 50.05 Billion GBP -13.35%
2021 57.76 Billion GBP -3.12%
2020 59.62 Billion GBP -2.79%
2019 61.33 Billion GBP 12.76%
2018 54.39 Billion GBP 2.84%
2017 52.89 Billion GBP -2.27%
2016 54.11 Billion GBP 21.43%
2015 44.56 Billion GBP 24.79%
2014 35.71 Billion GBP 4.2%
2013 34.27 Billion GBP -1.31%
2012 34.72 Billion GBP 7.67%
2011 32.25 Billion GBP -0.17%
2010 32.3 Billion GBP 0.58%
2009 32.12 Billion GBP 3.36%
2008 31.07 Billion GBP 47.32%
2007 21.09 Billion GBP 32.62%
2006 15.9 Billion GBP -18.97%
2005 19.62 Billion GBP 15.41%
2004 17 Billion GBP 10.46%
2003 15.39 Billion GBP 3.06%
2002 14.93 Billion GBP 10.1%
2001 13.56 Billion GBP 7.39%
2000 12.63 Billion GBP 74.66%
1999 7.23 Billion GBP 9.97%
1998 6.57 Billion GBP 0.47%
1997 6.54 Billion GBP -7.1%
1996 7.04 Billion GBP -15.3%
1995 8.32 Billion GBP 203.87%
1994 2.73 Billion GBP -2.25%
1993 2.8 Billion GBP 37.1%
1992 2.04 Billion GBP -17.02%
1991 2.46 Billion GBP 45.94%
1990 1.68 Billion GBP 45.93%
1989 1.15 Billion GBP 8.65%

Peer Total Liabilities Comparison of GSK plc

Name Total Liabilities Total Liabilities Difference
AstraZeneca PLC 61.86 Billion USD 25.306%
Bristol-Myers Squibb Company PFD CONV 2 65.67 Billion USD 29.637%
CSPC Pharmaceutical Group Limited 1.53 Billion USD -2901.013%
Clarus Therapeutics Holdings, Inc. 67.62 Million USD -68230.696%
Novartis AG 53.19 Billion USD 13.131%
PT Kalbe Farma Tbk. 255.94 Million USD -17954.978%